GleamWall
中文EN

LXRX LEXICON PHARMACEUTICALS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1062822 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-45.6%
TTM net income YoY9.1%
TTM EPS YoY21.1%
Revenue 3-yr CAGR317.1%
Net income 3-yr CAGR—

Margins

Gross margin98.9%
Operating margin-147.4%
Net margin-161.8%
FCF margin—
EBITDA margin-146.3%

Returns

ROE-43.9%
ROA-27.8%
ROIC (approx.)-33.3%
Asset turnover0.17x

Leverage & solvency

Liabilities / assets32.3%
Debt / equity0.32x
Current ratio10.63x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.79x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$49.80M$31.08M
Cost of revenue$274,000$616,000
Gross profit$49.53M$30.46M
R&D expense$61.12M$84.48M
SG&A expense$37.32M$143.10M
Operating income-$48.91M-$197.12M
Income tax—$0
Net income-$50.34M-$200.40M
EBITDA-$48.29M-$196.58M
EPS (basic)-0.14-0.63
EPS (diluted)-0.14-0.63
Weighted avg. shares (diluted)363.05M320.03M
Balance sheet
Cash & equivalents$34.33M$66.66M
Short-term investments$61.90M$171.30M
Receivables$2.38M$3.47M
Inventory$281,000$231,000
Current assets$101.89M$246.19M
PP&E, net$1.86M$2.48M
Goodwill$44.54M$44.54M
Total assets$184.99M$298.42M
Current liabilities$20.87M$45.25M
Short-term debt$4.59M$0
Long-term debt$49.41M$100.30M
Total debt$54.00M$100.30M
Total liabilities$77.45M$152.47M
Shareholders' equity$107.54M$145.95M
Net debt$19.68M$33.64M
Shares outstanding365.85M363.02M
Cash flow statement
Operating cash flow-$67.85M-$178.78M
Capital expenditure$0$1.03M
Free cash flow-$67.85M-$179.81M
Investing cash flow$113.02M-$15.38M
Financing cash flow-$48.50M$238.35M
Depreciation & amortization$621,000$534,000
Stock-based compensation$12.52M$13.50M
Share buybacks—$1.73M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.